{"component": "definition", "props": {"groups": [{"snippet": "or \u201cCommercialization\u201d means the marketing, promotion, sale (and offer for sale or contract to sell), distribution, importation or other commercial exploitation (including pricing and reimbursement activities) for a Product in the Territory. Commercialization shall include commercial activities conducted in preparation for Product launch.", "snippet_links": [{"key": "offer-for-sale", "type": "definition", "offset": [65, 79]}, {"key": "contract-to-sell", "type": "clause", "offset": [83, 99]}, {"key": "commercial-exploitation", "type": "clause", "offset": [137, 160]}, {"key": "pricing-and-reimbursement", "type": "clause", "offset": [172, 197]}, {"key": "in-the-territory", "type": "clause", "offset": [224, 240]}, {"key": "commercial-activities", "type": "definition", "offset": [274, 295]}, {"key": "preparation-for", "type": "clause", "offset": [309, 324]}, {"key": "product-launch", "type": "definition", "offset": [325, 339]}], "size": 688, "samples": [{"hash": "jiE7IlrKpW5", "uri": "/contracts/jiE7IlrKpW5#commercialize", "label": "Collaboration and License Agreement (Lyell Immunopharma, Inc.)", "score": 32.4360046387, "published": true}, {"hash": "dCQF4sNilTb", "uri": "/contracts/dCQF4sNilTb#commercialize", "label": "Collaboration and License Agreement (Ambrx Biopharma Inc.)", "score": 32.4031486511, "published": true}, {"hash": "lg7qArrpCHy", "uri": "/contracts/lg7qArrpCHy#commercialize", "label": "Collaboration and License Agreement (Lyell Immunopharma, Inc.)", "score": 32.3949356079, "published": true}], "hash": "21287a14ddadc439ef52f7d8e1ba2e21", "id": 1}, {"snippet": "means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.", "snippet_links": [{"key": "directed-to", "type": "definition", "offset": [17, 28]}, {"key": "research-and-development", "type": "clause", "offset": [51, 75]}, {"key": "as-required", "type": "clause", "offset": [76, 87]}, {"key": "offering-for-sale", "type": "definition", "offset": [113, 130]}], "size": 406, "samples": [{"hash": "gEdPHoyShYG", "uri": "/contracts/gEdPHoyShYG#commercialize", "label": "License Agreement (Regen BioPharma Inc)", "score": 36.8767967224, "published": true}, {"hash": "fG38CmS8WzI", "uri": "/contracts/fG38CmS8WzI#commercialize", "label": "License Agreement (Regen BioPharma Inc)", "score": 36.8767967224, "published": true}, {"hash": "6lLhIjO2HGS", "uri": "/contracts/6lLhIjO2HGS#commercialize", "label": "License Agreement (Regen BioPharma Inc)", "score": 36.8767967224, "published": true}], "hash": "fbee03c659f5c8bab1b2b46fd17c0146", "id": 2}, {"snippet": "means to engage in Commercialization.", "snippet_links": [], "size": 317, "samples": [{"hash": "3toa00iwQEj", "uri": "/contracts/3toa00iwQEj#commercialize", "label": "Financing Agreement (Scholar Rock Holding Corp)", "score": 37.1670074463, "published": true}, {"hash": "iNet9iJZ4C7", "uri": "/contracts/iNet9iJZ4C7#commercialize", "label": "Stock Purchase Agreement (Generate Biomedicines, Inc.)", "score": 37.117729187, "published": true}, {"hash": "3KC6IwwuAWJ", "uri": "/contracts/3KC6IwwuAWJ#commercialize", "label": "License Agreement (Generate Biomedicines, Inc.)", "score": 37.117729187, "published": true}], "hash": "e76e62b01bacfae00506802a27190268", "id": 3}, {"snippet": "and \u201cCommercializing\u201d shall have their correlative meanings.", "snippet_links": [], "size": 173, "samples": [{"hash": "djzN3iCCHYz", "uri": "/contracts/djzN3iCCHYz#commercialize", "label": "Asset Purchase Agreement (Black Titan Corp)", "score": 36.4168395996, "published": true}, {"hash": "3WLhcj8HdHl", "uri": "/contracts/3WLhcj8HdHl#commercialize", "label": "License Agreement (Scilex Holding Co)", "score": 36.1676940918, "published": true}, {"hash": "2oNgvg9UqDt", "uri": "/contracts/2oNgvg9UqDt#commercialize", "label": "License Agreement (Oramed Pharmaceuticals Inc.)", "score": 36.1676940918, "published": true}], "hash": "d6ea358db2a2714e24a2dbac77c399ee", "id": 4}, {"snippet": "has a correlative meaning.", "snippet_links": [], "size": 106, "samples": [{"hash": "eDmDpUo5YkN", "uri": "/contracts/eDmDpUo5YkN#commercialize", "label": "License Agreement (Jazz Pharmaceuticals PLC)", "score": 36.5947990417, "published": true}, {"hash": "8GRO6rsMFJY", "uri": "/contracts/8GRO6rsMFJY#commercialize", "label": "License and Option Agreement (Jazz Pharmaceuticals PLC)", "score": 36.5947990417, "published": true}, {"hash": "Gsv6PZQpjV", "uri": "/contracts/Gsv6PZQpjV#commercialize", "label": "Patent and Know How License Agreement (Alto Neuroscience, Inc.)", "score": 34.9876785278, "published": true}], "hash": "0684cb29c07abd53972a92d680fd4f0a", "id": 5}, {"snippet": "means any and all activities directed to marketing, promoting, detailing, distributing, importing, having imported, exporting, having exported, selling or offering to sell a \u2587\u2587\u2587\u2587\u2587 Therapeutic following receipt of Regulatory Approval for such \u2587\u2587\u2587\u2587\u2587 Therapeutic.", "snippet_links": [{"key": "directed-to", "type": "definition", "offset": [29, 40]}, {"key": "to-sell", "type": "clause", "offset": [164, 171]}, {"key": "a-\u2587", "type": "clause", "offset": [172, 175]}, {"key": "receipt-of-regulatory-approval", "type": "clause", "offset": [202, 232]}], "size": 63, "samples": [{"hash": "iAP6vBQXNDS", "uri": "/contracts/iAP6vBQXNDS#commercialize", "label": "License and Collaboration Agreement (Regulus Therapeutics Inc.)", "score": 32.364818573, "published": true}, {"hash": "3qUkQUY5P8p", "uri": "/contracts/3qUkQUY5P8p#commercialize", "label": "License and Collaboration Agreement (Regulus Therapeutics Inc.)", "score": 23.6255989075, "published": true}, {"hash": "dOePRN5k2bB", "uri": "/contracts/dOePRN5k2bB#commercialize", "label": "License and Collaboration Agreement (Isis Pharmaceuticals Inc)", "score": 21.0, "published": true}], "hash": "5acf15b6f01425d7e3774f6f3d333d06", "id": 6}, {"snippet": "means to promote, market, distribute, sell and provide product support for a Product, and \u201cCommercializing\u201d and \u201cCommercialization\u201d shall have correlative meanings.", "snippet_links": [{"key": "product-support", "type": "definition", "offset": [55, 70]}], "size": 54, "samples": [{"hash": "7mJlLFMNyyV", "uri": "/contracts/7mJlLFMNyyV#commercialize", "label": "Collaboration and License Agreement (Verve Therapeutics, Inc.)", "score": 33.8487319946, "published": true}, {"hash": "aSTf5Nj08py", "uri": "/contracts/aSTf5Nj08py#commercialize", "label": "Collaboration and License Agreement (Prime Medicine, Inc.)", "score": 33.0301170349, "published": true}, {"hash": "fSDlRsaQplS", "uri": "/contracts/fSDlRsaQplS#commercialize", "label": "Collaboration and License Agreement (Verve Therapeutics, Inc.)", "score": 32.4031486511, "published": true}], "hash": "cfd8ced7e1d7d8e7d26e1b9b579bd14e", "id": 7}, {"snippet": "means any and all activities directed to the commercialization of a Product, including pre-launch and post-launch marketing, manufacturing for commercial sale, promoting, Detailing (as defined in Schedule 5 hereof), distributing, offering to sell and selling a Product, importing a Product for sale, conducting additional human clinical studies other than those that are required due to post-approval regulatory commitments (but not pre-clinical studies) and interacting with Regulatory Authorities regarding the foregoing. When used as a verb, \u201cCommercializing\u201d means to engage in Commercialization and \u201cCommercialized\u201d has a corresponding meaning.", "snippet_links": [{"key": "directed-to", "type": "definition", "offset": [29, 40]}, {"key": "commercial-sale", "type": "clause", "offset": [143, 158]}, {"key": "schedule-5", "type": "clause", "offset": [196, 206]}, {"key": "to-sell", "type": "clause", "offset": [239, 246]}, {"key": "for-sale", "type": "definition", "offset": [290, 298]}, {"key": "clinical-studies", "type": "definition", "offset": [328, 344]}, {"key": "regulatory-commitments", "type": "clause", "offset": [401, 423]}, {"key": "regulatory-authorities", "type": "definition", "offset": [476, 498]}, {"key": "the-foregoing", "type": "definition", "offset": [509, 522]}], "size": 42, "samples": [{"hash": "4kdmCgnEV4b", "uri": "/contracts/4kdmCgnEV4b#commercialize", "label": "Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)", "score": 32.0965080261, "published": true}, {"hash": "fznsThnAVdv", "uri": "/contracts/fznsThnAVdv#commercialize", "label": "Collaborative Development & License Agreement", "score": 31.3390369415, "published": true}, {"hash": "23GorjdgR8Q", "uri": "/contracts/23GorjdgR8Q#commercialize", "label": "Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)", "score": 27.1054077148, "published": true}], "hash": "cc6e486b7090207ce96e53a504a6d460", "id": 8}, {"snippet": "means all activities directed to marketing, distribution, promoting or selling of pharmaceutical products (including importing and exporting activities in connection therewith), but excluding activities directed to Manufacturing.", "snippet_links": [{"key": "directed-to", "type": "definition", "offset": [21, 32]}, {"key": "pharmaceutical-products", "type": "definition", "offset": [82, 105]}, {"key": "in-connection", "type": "definition", "offset": [152, 165]}, {"key": "but-excluding", "type": "clause", "offset": [178, 191]}], "size": 40, "samples": [{"hash": "ea5MYOCTSDq", "uri": "/contracts/ea5MYOCTSDq#commercialize", "label": "License Agreement (Zai Lab LTD)", "score": 32.3538665771, "published": true}, {"hash": "dWfJQj0ksEe", "uri": "/contracts/dWfJQj0ksEe#commercialize", "label": "License Agreement (Zai Lab LTD)", "score": 32.1622161865, "published": true}, {"hash": "cNH8sLpABgu", "uri": "/contracts/cNH8sLpABgu#commercialize", "label": "License Agreement (Turning Point Therapeutics, Inc.)", "score": 31.6064338684, "published": true}], "hash": "d918d2b2f3eaee3a3706730d89224201", "id": 9}, {"snippet": "\u201cCommercializing,\u201d and \u201cCommercialized\u201d will be construed accordingly.", "snippet_links": [], "size": 38, "samples": [{"hash": "bV6U8rl6yfD", "uri": "/contracts/bV6U8rl6yfD#commercialize", "label": "Collaboration and Option Agreement (Cyclerion Therapeutics, Inc.)", "score": 37.2436676025, "published": true}, {"hash": "6mBcKFptqVb", "uri": "/contracts/6mBcKFptqVb#commercialize", "label": "Asset Purchase and License Agreement (Omeros Corp)", "score": 37.2436676025, "published": true}, {"hash": "ezBUdNGTTWC", "uri": "/contracts/ezBUdNGTTWC#commercialize", "label": "Exclusive License and Collaboration Agreement (Arrowhead Pharmaceuticals, Inc.)", "score": 36.8987007141, "published": true}], "hash": "803e89b29d7cfbe5d8defce9d282fcde", "id": 10}], "next_curs": "CloSVGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjYLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIWY29tbWVyY2lhbGl6ZSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "or \u201cCommercialization\u201d means the marketing, promotion, sale (and offer for sale or contract to sell), distribution, importation or other commercial exploitation (including pricing and reimbursement activities) for a Product in the Territory. Commercialization shall include commercial activities conducted in preparation for Product launch.", "title": "Commercialize", "size": 3396, "id": "commercialize", "examples": ["Subject to the confidentiality and use restrictions in Article 8, nothing in this Agreement shall limit or restrict the right of the Sanofi or its Affiliates to Develop, make regulatory filings, obtain regulatory approvals with respect to, or <strong>Commercialize</strong> any product or to engage in any business or other activity.", "During the Term, Scribe shall keep Sanofi reasonably informed about any new material Licensed Know-How or material improvements to the Licensed Technology, and, for the period beginning [*], Scribe shall provide any such know-how or improvements, in each case after Sanofi has provided a written request to receive such know-how or improvements, to enable Sanofi to Develop, manufacture, <strong>Commercialize</strong> or otherwise exploit the Licensed Products.", "Except as set forth in Schedule 2.17(a) or in the Material Licenses, the Company Group wholly owns or has the exclusive right and license to develop, manufacture, use and <strong>Commercialize</strong> the Product under the Product IP and the Product Assets."], "related": [["commercialise", "Commercialise", "Commercialise"], ["commercializing", "Commercializing", "Commercializing"], ["commercialized", "Commercialized", "Commercialized"], ["commercialization", "Commercialization", "Commercialization"], ["licensed-products", "Licensed Products", "Licensed Products"]], "related_snippets": [], "updated": "2026-07-04T05:45:54+00:00"}, "json": true, "cursor": ""}}